Cargando…

Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016

BACKGROUND: Estimates of contralateral breast cancer (CBC) risk in the modern treatment era by year of diagnosis and characteristics of the first breast cancer are needed to assess the impact of recent advances in breast cancer treatment and inform clinical decision making. METHODS: We examined CBC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramin, Cody, Withrow, Diana R., Davis Lynn, Brittny C., Gierach, Gretchen L., de González, Amy Berrington
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890613/ https://www.ncbi.nlm.nih.gov/pubmed/33596988 http://dx.doi.org/10.1186/s13058-021-01400-3

Ejemplares similares

Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region
por: Davis Lynn, Brittny C, et al.
Publicado: (2021)

Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort
por: Ramin, Cody, et al.
Publicado: (2023)

Associations between quantitative measures of TDLU involution and breast tumor molecular subtypes among breast cancer cases in the Black Women’s Health Study: a case–case analysis
por: Davis Lynn, Brittny C., et al.
Publicado: (2022)

Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017
por: Vo, Jacqueline B., et al.
Publicado: (2022)

Risk of contralateral second primary breast cancer according to hormone receptor status in Germany
por: Rusner, Carsten, et al.
Publicado: (2014)

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients
por: Sherman, Mark E., et al.
Publicado: (2016)

Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients
por: Mullooly, Maeve, et al.
Publicado: (2019)

Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: an analysis of death certificate data by county from 2000–15
por: Shiels, Meredith S, et al.
Publicado: (2019)

Trends in Alcohol-Induced Deaths in the United States, 2000-2016
por: Spillane, Susan, et al.
Publicado: (2020)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography
por: Gierach, Gretchen L., et al.
Publicado: (2022)

Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect
por: Shaikh, Asim Jamal, et al.
Publicado: (2018)

MRI evaluation of the contralateral breast in patients with recently diagnosed breast cancer
por: Taneja, Sangeeta, et al.
Publicado: (2012)

Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy
por: Davies, Kalatu R, et al.
Publicado: (2015)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

Leading cancers contributing to educational disparities in cancer mortality in the US, 2017
por: Withrow, Diana R., et al.
Publicado: (2021)

Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer
por: LI, ZHENG, et al.
Publicado: (2015)

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
por: Langballe, Rikke, et al.
Publicado: (2016)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Axillary metastasis from occult breast cancer and synchronous contralateral breast cancer initially suspected to be cancer with contralateral axillary metastasis: a case report
por: Song, Myung Won, et al.
Publicado: (2021)

Breast cancer gene expression datasets do not reflect the disease at the population level
por: Xie, Yanping, et al.
Publicado: (2020)

Only one breast remains at risk of contralateral cancer
por: Peto, R.
Publicado: (1987)

Risk of contralateral breast cancer in Denmark 1943-80.
por: Storm, H. H., et al.
Publicado: (1986)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Homicide in Denmark 1992–2016
por: Thomsen, Asser H., et al.
Publicado: (2019)

The Evaluation of Contralateral Breast Lesions in Breast Cancer Patients Using Reduction Mammoplasty
por: Dogan, Lutfi, et al.
Publicado: (2011)

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
por: Verhoog, L C, et al.
Publicado: (2000)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Prediction of outcome after diagnosis of metachronous contralateral breast cancer
por: Alkner, Sara, et al.
Publicado: (2011)

Breast cancer with an intraductal component that was proven genetically to be metastasis of contralateral breast cancer: a case report
por: Shinden, Yoshiaki, et al.
Publicado: (2020)

Nomogram to predict contralateral breast cancer risk in breast cancer survivors: A SEER-based study
por: Tong, Jiaci, et al.
Publicado: (2021)

Association between mammographic density and basal-like and luminal A breast cancer subtypes
por: Razzaghi, Hilda, et al.
Publicado: (2013)

Prediction and clinical utility of a contralateral breast cancer risk model
por: Giardiello, Daniele, et al.
Publicado: (2019)

The Prevalence of Hardship by Race and Ethnicity in the USA, 1992–2019
por: Iceland, John, et al.
Publicado: (2022)

The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
por: Nout, R. A., et al.
Publicado: (2007)

Contralateral breast dose from partial breast brachytherapy
por: Robinson, R. Cole, et al.
Publicado: (2015)

Adenomyoepithelioma of the Breast in the Setting of Prior Contralateral Breast Malignancy
por: Dauterman, Leah C, et al.
Publicado: (2023)

Intra-individual Gene Expression Variability of Histologically Normal Breast Tissue
por: Sun, Xuezheng, et al.
Publicado: (2018)

Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort
por: Wang, Shao-Ming, et al.
Publicado: (2020)

Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tubqatrqk7r096kp6340b85gl3